Catherine Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Catherine Shen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Aaron T. Zhao
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2 shared publications - Aretha On
Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA
2 shared publications - Victoria P. Werth
Corporal Michael J. Crescenz Veterans Affairs Medical Center Philadelphia, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
2 shared publications - Alannah Hill
Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
1 shared publication Ann Marie Pammer
Dermatology and Mohs Surgery Center, An Affiliate of Anne Arundel Dermatology Doylestown Pennsylvania USA
1 shared publicationAri Zeidi
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA
1 shared publication
Latest Publications
- 22 August 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (11) , 2999-3010
Chimeric antigen receptor T-cell therapy in dermatologic autoimmunity: Mechanisms, applications, and future directions
- 22 August 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (11) , 2999-3010
Chimeric antigen receptor T-cell therapy in dermatologic autoimmunity: Mechanisms, applications, and future directions
- 24 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (4) , 779-781
Normal muscle enzyme levels in classic dermatomyositis: implications for clinical trial endpoints
Muscle involvement in dermatomyositis can present without muscle enzyme elevations in 26–48% of patients. These findings are important to acknowledge in order to interpret muscle enzyme testing within the broader clinical context.
- 24 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (4) , 779-781
Normal muscle enzyme levels in classic dermatomyositis: implications for clinical trial endpoints
Muscle involvement in dermatomyositis can present without muscle enzyme elevations in 26–48% of patients. These findings are important to acknowledge in order to interpret muscle enzyme testing within the broader clinical context.
- Open Access
- 1 July 2025
- Published by BMJ in Lupus Science & Medicine
- Vol. 12 (2) , e001803
Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review
Objective: To systematically identify herbal supplements with immunostimulatory properties that may trigger or exacerbate autoimmune skin diseases. Methods: We conducted a systematic scoping review in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines. PubMed was searched for studies published before 3 August 2025 using predefined immune, herbal supplement, autoimmune, skin and interferon terms. Articles in English that described immunostimulatory effects of herbal supplements in vitro, in model organisms or in human/clinical studies were included. Data were extracted by four reviewers and synthesised qualitatively, with herbs categorised according to levels of supporting evidence for their immunostimulatory properties. A subgroup of herbs with the strongest evidence was identified based on predefined criteria. Results: From 11 819 unique articles screened, 469 studies met inclusion criteria. Across these, 227 distinct immunostimulatory herbal supplements were identified: 79 supported by human studies, 145 by model organism studies and 148 by in vitro studies. 15 herbs demonstrated the most robust evidence across all three evidence types, supported by more than five single-ingredient studies or more than 25 references overall. These included alfalfa, ashwagandha, astragalus, chlorella, echinacea, garlic, ginseng, green tea extract, Indian mulberry, liquorice, mistletoe, reishi mushroom, skullcap, spirulina and tinospora. These herbs were widely marketed for ‘immune support’ and shared proinflammatory mechanisms, including toll-like receptor activation, NF-κB/MAPK signalling and increased production of inflammatory cytokines including IL-1β, IL-6, TNF-α, IL-12 and IFN-γ. Conclusions: We identified 227 herbal supplements with immunostimulatory properties, of which 15 were most strongly supported by the evidence. This article may serve as a reference to help clinicians counsel patients with autoimmune skin diseases on the risks associated with use of specific herbal supplements.
- 1 July 2025
- Published by BMJ in Lupus Science & Medicine
- Vol. 12 (2) , e001803
Open AccessIdentifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review
Objective: To systematically identify herbal supplements with immunostimulatory properties that may trigger or exacerbate autoimmune skin diseases. Methods: We conducted a systematic scoping review in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines. PubMed was searched for studies published before 3 August 2025 using predefined immune, herbal supplement, autoimmune, skin and interferon terms. Articles in English that described immunostimulatory effects of herbal supplements in vitro, in model organisms or in human/clinical studies were included. Data were extracted by four reviewers and synthesised qualitatively, with herbs categorised according to levels of supporting evidence for their immunostimulatory properties. A subgroup of herbs with the strongest evidence was identified based on predefined criteria. Results: From 11 819 unique articles screened, 469 studies met inclusion criteria. Across these, 227 distinct immunostimulatory herbal supplements were identified: 79 supported by human studies, 145 by model organism studies and 148 by in vitro studies. 15 herbs demonstrated the most robust evidence across all three evidence types, supported by more than five single-ingredient studies or more than 25 references overall. These included alfalfa, ashwagandha, astragalus, chlorella, echinacea, garlic, ginseng, green tea extract, Indian mulberry, liquorice, mistletoe, reishi mushroom, skullcap, spirulina and tinospora. These herbs were widely marketed for ‘immune support’ and shared proinflammatory mechanisms, including toll-like receptor activation, NF-κB/MAPK signalling and increased production of inflammatory cytokines including IL-1β, IL-6, TNF-α, IL-12 and IFN-γ. Conclusions: We identified 227 herbal supplements with immunostimulatory properties, of which 15 were most strongly supported by the evidence. This article may serve as a reference to help clinicians counsel patients with autoimmune skin diseases on the risks associated with use of specific herbal supplements.
- Open Access
- 12 June 2025
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 8, e69796
The Influence of Popular Media on Public Interest in Red-Light Therapy: Longitudinal Trend Analysis
TikTok’s influence has significantly increased public interest in red-light therapy, surpassing that for traditional skin care treatments; this highlights the powerful role of social media in shaping health care trends and underscores the need for health care providers to stay informed about viral social media trends on treatment.
- 12 June 2025
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 8, e69796
Open AccessThe Influence of Popular Media on Public Interest in Red-Light Therapy: Longitudinal Trend Analysis
TikTok’s influence has significantly increased public interest in red-light therapy, surpassing that for traditional skin care treatments; this highlights the powerful role of social media in shaping health care trends and underscores the need for health care providers to stay informed about viral social media trends on treatment.
- 8 January 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 192 (5) , 943-945
Erythema variation in dermatomyositis across subtypes and racial groups: importance of outcome measure for dermatomyositis clinical trials
Two measurement tools are currently used to assess skin disease activity in dermatomyositis (DM) clinical trials: the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA). This cross-sectional study assessed variability in erythema presentation across DM subtypes and among racial groups by comparing these two measurement tools: the CDASI and the CDM-IGA. With the increasing need to standardize DM trial outcome measures for cutaneous disease, our findings support the use of the CDASI as the primary scoring tool to determine cutaneous trial outcomes.
- 8 January 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 192 (5) , 943-945
Erythema variation in dermatomyositis across subtypes and racial groups: importance of outcome measure for dermatomyositis clinical trials
Two measurement tools are currently used to assess skin disease activity in dermatomyositis (DM) clinical trials: the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA). This cross-sectional study assessed variability in erythema presentation across DM subtypes and among racial groups by comparing these two measurement tools: the CDASI and the CDM-IGA. With the increasing need to standardize DM trial outcome measures for cutaneous disease, our findings support the use of the CDASI as the primary scoring tool to determine cutaneous trial outcomes.
- Open Access
- 8 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
The Influence of Popular Media on Public Interest in Red Light Therapy and Implications for Evidence-Based Practice (Preprint)
BACKGROUND Social media platforms, particularly TikTok, have emerged as influential sources of medical information and treatment trends. In early 2024, red light therapy gained substantial attention on TikTok for skincare applications, despite limited scientific understanding of its long-term effects and safety profile with home use. OBJECTIVE To quantify the impact of TikTok exposure on public interest in red light therapy and compare interest trends with conventional skincare treatments. METHODS We analyzed Google Trends data from November 2019 to November 2024 for red light therapy-related terms and control terms. Statistical analyses included trend analysis and structural break detection. RESULTS Search interest for red light therapy terms showed significant increases post-February 2024 (p<0.001) compared to the previous year. Linear regression revealed significant positive trends for red light therapy terms while control terms showed either no significant trends or slight declines. CONCLUSIONS TikTok's influence significantly increased public interest in red light therapy, surpassing traditional skincare treatments. These findings highlight social media's role in shaping healthcare trends and underscore the need for healthcare providers to stay informed about viral treatments.
- 8 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Influence of Popular Media on Public Interest in Red Light Therapy and Implications for Evidence-Based Practice (Preprint)
BACKGROUND Social media platforms, particularly TikTok, have emerged as influential sources of medical information and treatment trends. In early 2024, red light therapy gained substantial attention on TikTok for skincare applications, despite limited scientific understanding of its long-term effects and safety profile with home use. OBJECTIVE To quantify the impact of TikTok exposure on public interest in red light therapy and compare interest trends with conventional skincare treatments. METHODS We analyzed Google Trends data from November 2019 to November 2024 for red light therapy-related terms and control terms. Statistical analyses included trend analysis and structural break detection. RESULTS Search interest for red light therapy terms showed significant increases post-February 2024 (p<0.001) compared to the previous year. Linear regression revealed significant positive trends for red light therapy terms while control terms showed either no significant trends or slight declines. CONCLUSIONS TikTok's influence significantly increased public interest in red light therapy, surpassing traditional skincare treatments. These findings highlight social media's role in shaping healthcare trends and underscore the need for healthcare providers to stay informed about viral treatments.